FireCyte Therapeutics
Beverly · Founded 2021
About FireCyte Therapeutics
FireCyte Therapeutics is developing treatment for microglia and neuroinflammation in progressive neurodegenerative eye diseases.
Company Facts
- Founded: 2021
- Operating status: Operating
- IPO status: Private
- Last round: Series Unknown (Jan 2024)
- Website: firecyte.com
Canonical: https://fsome.com/organization/firecyte-therapeutics-8309710 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.